Short ReportDelay in referral to a specialist soft-tissue sarcoma unit
Introduction
Soft-tissue sarcomas are rare tumours, with around 1200 new cases per year in the UK. They typically present with an enlarging painless mass anywhere in the body. While most large (>5 cm) or enlarging soft-tissue masses will be benign (in a ratio of about 100:1),1 the consequences of a malignant diagnosis are such that patients with suspected soft-tissue sarcoma should be rapidly referred by their General Practitioner (GP) for specialist opinion without imaging or biopsy being performed.2 However, this optimal pathway often fails to happen, and delays are frequent.3, 4 From experience we knew that delay in referral was common, and we decided to assess the problem objectively and prospectively.
There are many reasons why patients with soft-tissue sarcoma are not diagnosed promptly. The patient may not present to the GP. The GP may not recognise the nature of the condition. If recognised, there may be delays in referral to a hospital specialist, and thereafter for imaging, biopsy, or biopsy reporting. Once soft-tissue sarcoma is suspected or diagnosed, there may be a delay in tertiary referral or access. The cumulative effect of these events may be the significant passage of time from the initial complaint, or inappropriate treatment of the patient, both of which may jeopardise outcome.5
We prospectively evaluated new referrals to our specialist unit to determine the proportion of patients with significant delays in referral, and identify the causes of delay.
Section snippets
Patients, methods, and results
All new National Health Service (NHS) surgical referrals seen in the Soft-Tissue Sarcoma Unit of the Royal Marsden Hospital for the one-year period from April 1st 2003 to March 31st 2004 were considered. The patients were seen here within two weeks of referral, during which time any previous imaging or biopsy was obtained and reviewed. All patients were assessed by one or both of the authors, who are Consultant Surgical Oncologists with a special interest in sarcoma. Details of the chronology
Results
Thirty-one patients were identified with delayed referral during this period (Table 1). This represented 19.5% of the 159 patients seen in our unit with proven STS in the same period. (A total of 216 patients with benign and malignant soft-tissue tumours were evaluated during this time.) There were 12 men and 19 women, with a median age of 59 years (range 34–84 years). The median overall time from presentation to the GP to being seen in our unit was 14 months (range 4–96 months, average 22±4
Discussion
We knew from experience that delays in referral to our Soft-Tissue Sarcoma Unit were common and that there were errors ‘en route’. Others have reported on similar experiences.4, 5, 6 This prospective study was, therefore, undertaken to quantitate the delay and to investigate its components. The results are disturbing. We defined delay in referral as three months or greater from the time of first presentation to a doctor, and some will consider this definition generous. Nevertheless a median
References (14)
- et al.
Delay in diagnosis of soft tissue sarcomas
Eur J Surg Oncol
(2003) - et al.
Conformity to clinical practice guidelines, multidisciplinary management and outcomes of treatment for soft tissue sarcomas
Ann Oncol
(2004) - et al.
Amputation for soft-tissue sarcoma
Lancet Oncol
(2003) - et al.
Soft tissue tumors
(1995) A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas
Acta Orthop Scand
(1981)- et al.
Analysis of the referral pattern to a supraregional bone and soft tissue tumour service
Ann R Coll Surg Eng
(2003) - et al.
Variable management of soft tissue sarcoma: regional audit with implications for specialist care
Br J Surg
(1997)